WELLESLEY HILLS, Mass.--(BUSINESS WIRE)--BioBridges, LLC, a clinical development consultancy serving the biopharmaceutical community, announced today the appointment of David P. Lucey as Director of ClinPath.
“BioBridges is at a very exciting and critical stage in its lifecycle. We are positioned for rapid growth and plan on providing unparalleled services to our clients and opportunities for our staff”
Mr. Lucey will develop and market ClinPath’s Functional Outsourcing program while also providing key operational expertise in its management. With over 20 years of industry experience, Dave has been instrumental in designing, implementing and managing “best in class” outsourcing programs.
“Dave joins BioBridges at a very exciting time in the marketplace as we experience continued growth for our high quality services. Whether it is through partnerships, acquisitions, setting up residence or making this their new home, so many bio-pharma organizations see the incredible value in establishing a strong presence in MA to leverage the education, clinical community, and incredible talent the commonwealth has to offer. As our clients continue to focus on expanding current indications and developing new and exciting therapies they seek more flexible, targeted and immediate resourcing models to support them. Equally important, the days of 15, 10 and even 5 year tenures at one company are far and few. What is becoming more and more obvious is that through our continued commitment to our model, career development through new and exciting programs and managing and protecting one’s livelihood, working at BioBridges is not viewed as a stop along the way but a career path of the present and future. Dave’s deep experience in pharma, pioneering and running a leading functional service provider program, coupled with our proven success with ClinPoint & ClinPath in the local market will strengthen and ensure our commitment to our clients and consultants to the brand we launched 8 years ago,” said Jason Falchuk, Managing Partner, BioBridges.
“BioBridges is at a very exciting and critical stage in its lifecycle. We are positioned for rapid growth and plan on providing unparalleled services to our clients and opportunities for our staff,” commented Dave.
Prior to joining BioBridges, Dave was Director, Clinical Operations at ExecuPharm, King of Prussia, PA. He managed ExecuPharm’s outsourced clinical trial management program for Pfizer and oversaw 300 clinical operations employees.
Dave received his Bachelor of Science from Springfield College. Prior to his position at ExecuPharm, Dave was a Manager of Clinical Study & Data Management at Pfizer Inc., New York, NY.
About BioBridges, LLC
BioBridges leverages decades of experience successfully staffing and managing clinical trials in a wide range of therapeutic areas. Its services ClinPath and ClinPoint help emerging clinical organizations to “build bridges” between all areas of the clinical development lifecycle—from protocol inception through execution and submission. BioBridges can be reached at www.biobridges.com or 781.416.0909.